Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Reexamination Certificate
2008-03-04
2008-03-04
Kishore, Gollamudi S. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
C514S045000
Reexamination Certificate
active
07338666
ABSTRACT:
Methods for modulating the axonal outgrowth of central nervous system neurons are provided. Methods for stimulating the axonal outgrowth of central nervous system neurons following an injury (e.g., stroke, Traumatic Brain Injury, cerebral aneurism, spinal cord injury and the like) and methods for inhibiting the axonal outgrowth of central nervous system neurons are also provided. Finally, a packed formulation comprising a pharmaceutical composition comprising an inosine nucleoside and a pharmaceutically acceptable carrier packed with instructions for use of the pharmaceutical composition for treatment of a central nervous system disorder is provided.
REFERENCES:
patent: 4341868 (1982-07-01), Nakanishi et al.
patent: 4883666 (1989-11-01), Sabel et al.
patent: 5187162 (1993-02-01), Marangos et al.
patent: 5250414 (1993-10-01), Schwab et al.
patent: 5422343 (1995-06-01), Yamamoto et al.
patent: 5438130 (1995-08-01), Goldin et al.
patent: 5447939 (1995-09-01), Glasky et al.
patent: 6440455 (2002-08-01), Benowitz
patent: 6551612 (2003-04-01), Benowitz
patent: 6855690 (2005-02-01), Benowitz
patent: 74015765 (1974-04-01), None
patent: 2063753 (1996-07-01), None
patent: WO 94/00132 (1994-01-01), None
patent: WO 97/03652 (1997-02-01), None
patent: WO 88/09335 (1998-12-01), None
Benowitz, L.I., et al.;Dept. of Neuroscience Abstracts; 23(1-2) (1997).
Bold, J.M., et al.;Br. J. Pharmac.; 84:689-696 (1985).
Braumann, T., et al.;J. of Neurochem.; 912-919 (1986).
Christjanson, L.J., et al.;GLIA; 7:176-182 (1993).
Greene, L.A., et al.;J. of Neuroscience; 10(5):1479-1485 (1990).
Gysbers, J.W., et al.;NeuroReport; 3(11):997-1000 (1992).
Gysbers, J.W., et al.;Int. J. Dev. Neuroscience; 14(1):19-34 (1996).
Hayashi, E., et al.;Euro. J. of Pharmac.; 48:297-307 (1978).
Huffaker, T., et al.;J. of Cellular Physiology; 120:188-196 (1984).
Juhasz-Nagy, A., et al.;J. of Pahrac. And Experimental Therapeutics; 202(3):683-695 (1977).
Matz, H., et al.;J. of Neuroscience Research; 24:260-267 (1989).
Nagasawa, H., et al.;Neuroscience Letters; 133:129-132 (1991).
Rathbone, M.P., et al.;Medical Hypotheses; 37:232-240 (1992).
Rolls, E.T., et al.;Physiology&Behavior; 59(4/5):991-1000 (1996).
Satoh, T., et al.;Mol. Cell Biol.; 7(12):4553-4556 (1987).
Schwalb, J.M., et al.;Neuroscience; 72(4):901-910 (1996).
Schwalb, J.M., et al.;J. of Neuroscience; 15(8):5514-5525 (1995).
Standaert, F.G., et al.;J. of Pharmac. And Experimental Therapeutics; 199(3):544-552 (1976).
Svensson, B., et al.;Euro. J. of Neuroscience; 5:1017-1023 (1993).
Volonte, C., et al.;The J. of Cell Bio.; 109:2395-2403 (1989).
Wakade, T.D., et al.;J. of Physiology; 488(1):123-138 (1995).
Zarbin, M.A.; et al.;Exp. Brain Res.; 81:267-278 (1990).
Zurn, A.D., et al.;Proc. Natl. Acad. Sci. USA; 85:8301-8305 (1998).
Takeo et al.;J. Mol. Cell. Cardiol.; 20(3):187-199 (1998).
Children's Medical Center Corporation
Kishore Gollamudi S.
Nixon & Peabody LLP
LandOfFree
Methods for modulating the axonal outgrowth of central... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for modulating the axonal outgrowth of central..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for modulating the axonal outgrowth of central... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2813910